![Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease - Kidney International Reports Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease - Kidney International Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/3eb6461a-aa0f-4e31-b15c-52e37b516907/gr1.jpg)
Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease - Kidney International Reports
![Impact of bedside diagnosis of influenza in the paediatric emergency ward - Clinical Microbiology and Infection Impact of bedside diagnosis of influenza in the paediatric emergency ward - Clinical Microbiology and Infection](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9d3b5b18-d5ae-4d0d-918f-16ab38cdcb9f/gr1_lrg.jpg)
Impact of bedside diagnosis of influenza in the paediatric emergency ward - Clinical Microbiology and Infection
![Isomorphic red blood cells (RBCs) and dysmorphic RBCs, 400×. B: bright... | Download Scientific Diagram Isomorphic red blood cells (RBCs) and dysmorphic RBCs, 400×. B: bright... | Download Scientific Diagram](https://www.researchgate.net/profile/Chii-Wann-Lin/publication/312403107/figure/fig1/AS:458273179607040@1486272248893/Isomorphic-red-blood-cells-RBCs-and-dysmorphic-RBCs-400-B-bright-field-microscope.png)
Isomorphic red blood cells (RBCs) and dysmorphic RBCs, 400×. B: bright... | Download Scientific Diagram
![Peptides in Plasma, Urine, and Dialysate: Toward Unravelling Renal Peptide Handling - He - 2021 - PROTEOMICS – Clinical Applications - Wiley Online Library Peptides in Plasma, Urine, and Dialysate: Toward Unravelling Renal Peptide Handling - He - 2021 - PROTEOMICS – Clinical Applications - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/925abfe2-02d1-4605-8cab-7e7feaa67eeb/prca2141-fig-0004-m.jpg)
Peptides in Plasma, Urine, and Dialysate: Toward Unravelling Renal Peptide Handling - He - 2021 - PROTEOMICS – Clinical Applications - Wiley Online Library
![Frontiers | Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics | Oncology Frontiers | Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics | Oncology](https://www.frontiersin.org/files/Articles/672262/fonc-11-672262-HTML-r1/image_m/fonc-11-672262-g001.jpg)
Frontiers | Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics | Oncology
![Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS](https://www.pnas.org/cms/10.1073/pnas.1901734117/asset/ca49ecf3-6b2a-4a20-ac52-13201c1f3c84/assets/graphic/pnas.1901734117fig03.jpeg)
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
![Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-019-0267-8/MediaObjects/41408_2019_267_Fig1_HTML.png)